By Wendy Van Sickle
Columbus, Ohio, Aug. 30 – UBS AG, London Branch priced $1.28 million of 0% trigger autocallable contingent yield notes due March 5, 2018 linked to the common stocks of Celgene Corp. and Qualcomm Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 10.25% if each stock closes at or above its coupon barrier level, 80% of its initial level, on the observation date for that quarter.
The notes will be called at par if each stock closes at or above its initial level on any quarterly observation date prior to the final date.
The payout at maturity will be par unless either stock finishes below the downside threshold level, 80% of its initial level, in which case investors will lose 1% for every 1% decline of the worse performing stock.
UBS Securities LLC and UBS Investment Bank are the bookrunners.
| Issuer: | UBS AG, London Branch
|
| Issue: | Trigger autocallable contingent yield notes
|
| Underlying stocks: | Celgene Corp. and Qualcomm Inc.
|
| Amount: | $1.28 million
|
| Maturity: | March 5, 2018
|
| Coupon: | 10.25%, payable quarterly if each stock closes at or above coupon barrier level on observation date
|
| Price: | Par of $10
|
| Call: | At par plus contingent coupon if each stock closes at or above initial level on any quarterly observation date prior to the final date
|
| Payout at maturity: | Par unless either stock finishes below downside threshold level, in which case 1% loss for each 1% decline of the worse performing index
|
| Initial levels: | $131.65 for Celgene, $51.81for Qualcomm
|
| Barriers/thresholds: | $105.32 for Celgene, $41.45 for Qualcomm, 80% of initial levels
|
| Pricing date: | Aug. 28
|
| Settlement date: | Aug. 31
|
| Agents: | UBS Securities LLC and UBS Investment Bank
|
| Fees: | 1.85%
|
| Cusip: | 90270KMH9
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
